Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hoelz
Clifford Hoelz, Phoenix, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20110099069 | System and Method of Presenting a Commercial Product by Inserting Digital Content Into a Video Stream - In a commerce system, a commercial product is presented by transmitting a video stream through a communication link to present as an image on a video display. The image including a representation of the commercial product. An interactive device is used by a consumer to select a portion of the image on the video display representing the commercial product. The information related to the commercial product, such as product description, price, and ordering, is retrieved from a database or electronic search based on the selected portion of the image on the video display. Digital content containing the information related to the commercial product is generated by an adverting agent, manufacturer, or retailer. The digital content is inserted into the video stream to form composite video. The composite video is displayed on the video display to assist the consumer in completing a transaction to acquire the commercial product. | 04-28-2011 |
Derek J. Hoelz, Indianapolis, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20080220540 | Method for purifying cancer-specific proliferating cell nuclear antigen - The method for developing an antibody that exclusively binds to csPCNA. | 09-11-2008 |
| 20090061432 | CSPCNA ISOFORM MODIFICATIONS AND USES THEREOF - Methods and compositions to detect the presence of csPCNA isoform by identifying one or more posttranslational modifications are disclosed. Methods to identify csPCNA isoform through posttranslational modifications including methylesterification levels are disclosed. | 03-05-2009 |
| 20100240874 | METHOD FOR PURIFYING CANCER-SPECIFIC PROLIFERATING CELL NUCLEAR ANTIGEN - An isolated antibody that binds a cancer specific Proliferating Cell Nuclear Antigen (csPCNA) that binds to the amino acid sequence LeuLysGlnLeuAspAlaGlnGlnThrGlnLeuArgIle AspSerPhePheArgLeuAlaGlnGlnGluLysGluAspAlaLysArg (SEQ ID No. 1). An immunoassay that utilizes an isolated antibody that binds a form of csPCNA that binds to the SEQ ID No. 1 to identify the presence of csPCNA in a sample. | 09-23-2010 |
Derek J. Hoelz, Bangor, ME US
| Patent application number | Description | Published |
|---|---|---|
| 20110195510 | csPCNA Isoform Modifications And Uses Thereof - Methods and compositions to detect the presence of csPCNA isoform by identifying one or more posttranslational modifications are disclosed. Methods to identify csPCNA isoform through posttranslational modifications including methylesterification levels are disclosed. | 08-11-2011 |
Hubert Hoelz, Oberheimbach DE
| Patent application number | Description | Published |
|---|---|---|
| 20080197045 | Medicament Blister - The present invention relates to medicament blisters for powder inhalers. The blisters according to the invention contain an inhalable powder comprising a medicament. The blisters are characterised by a reduced permeability for water vapour, which is achieved by decreasing the height of the sealing lacquer layer. | 08-21-2008 |
| 20080295578 | Method for Checking the Permeability Rate of a Closed Container - In a method for checking the permeability rate of a closed container ( | 12-04-2008 |
| 20090092559 | Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant - The invention relates to pressurized gas formulations for dosage aerosols, in which a medicament is formulated suspended in TG 227 ea (1,1,1,2,3,3,3-heptafluoropropane) and/or TG 134 a (1,1,1,2-tetrafluoroethane) as a propellant, and to their use for producing a medicament. The aerosol is preferably an inhalation aerosol. | 04-09-2009 |
| 20100327476 | METHOD AND DEVICE FOR FILLING CAPSULES - The invention relates to a method for filling a capsule with a pharmaceutical active-substance formulation, wherein the capsule consists of two capsule parts (a capsule body and a capsule cap) and the two capsule parts, without being previously interlocked when empty, are only fitted together in a telescopic manner once one capsule part has been filled with a pharmaceutical active-substance formulation, as well as a device for this purpose. | 12-30-2010 |
| 20110186044 | DOSAGE AEROSOLS FOR THE APPLICATION OF PHARMACEUTICAL FORMULATIONS - The invention relates to pharmaceutical active substances, active substance mixtures and formulations for use as an aerosol in propellant-containing [1.1.1.2-tetrafluoroethane (HFC-134a) or 1.1.1.2.3.3.3-heptafluoropropane(HFC-227)] metered-dose aerosols and the metered-dose aerosols for administering these active substances, active substance mixtures and formulations. | 08-04-2011 |